Dr. John Maraganore served as the founding CEO and a Director of Alnylam from 2002 to 2021, where he built and led the company from early platform research on RNA interference through global approval and commercialization of the first four RNAi therapeutic medicines, ONPATTRO®, GIVLAARI®, OXLUMO®, and Leqvio®. At Alnylam, he also led the company’s… Continue reading John M. Maraganore
Katie Hope joined the Harvard T.H. Chan School of Public Health as its Chief Financial Officer in December 2011 after having worked in a variety of educational, non-profit and governmental organizations. In February, 2020, Katie became the School’s Executive Dean for Administration. Prior to coming to the Chan School, Katie was at UMass Boston. In her… Continue reading Katie Hope
Paul J. Anderson is the K. Frank Austen Professor of Medicine at Harvard Medical School and the associate chief of the Division of Rheumatology, Inflammation, and Immunity at Brigham and Women’s Hospital. He is a member of the American Society for Clinical Investigation and the Association of American Physicians and serves on the Scientific Advisory… Continue reading Paul J. Anderson
Robert S.D. Higgins, MD, MSHA, serves as president of Brigham and Women’s Hospital (BWH) and executive vice president at Mass General Brigham, roles he assumed in December 2021. As president, Higgins is responsible for the vitality and success of the clinical, academic and educational mission of the Brigham in support of patients locally and across… Continue reading Robert S.D. Higgins
Karin S. Leschly, MD, FAAFP, serves as the Medical Director of Quality Improvement and Population Health at the East Boston Neighborhood Health Center, one of the largest federally qualified community health centers in the nation.
Elliot Cohen is the co-founder and Chief Product Officer of PillPack, which was acquired by Amazon in 2018. He is a senior lecturer at MIT’s Sloan School of Management and a Founder Partner at Founder Collective. Prior to co-founding PillPack, he founded and directed MIT’s Hacking Medicine program. Mr. Cohen graduated from UC Berkeley with… Continue reading Elliot Cohen
Michelle Williams, ScD, SM, MS, is the Dean of Harvard T.H. Chan School of Public Health. Prior to her appointment as Dean, Williams was the chair of the Epidemiology Department and a Stephen B. Kay Family Professor of Public Health and Global Health and Population at the Harvard T.H. Chan School of Public Health. She… Continue reading Michelle Williams
Peter Hecht, Ph.D has served as Ironwood’s CEO and a director since co‐founding the company in 1998. He started Ironwood because he was attracted to “the idea of working with a team of people who challenge, inspire and humble me,” and building an enduring organization dedicated to creating important medicines.
Gwill York, MBA, is a pioneering entrepreneur with 30 years of experience financing early-stage technology and healthcare companies. Gwill co-founded Lighthouse Capital Partners in 1994, a structured venture capital partnership based in Cambridge and Menlo Park. At Lighthouse, she led investments in companies such as Vertex Pharmaceuticals, Millennium Pharmaceuticals, Cascade Communications, Sirocco Systems, Speechworks, Storage… Continue reading Gwill York
Jason Yeung, M.Phil. is a managing director and portfolio manager at Morgan Stanley with a focus on Investment Management Growth Funds. His career has focused on investments in the healthcare space. He also serves as a board member of Lifebox Foundation Inc. and co-chair of the Young Partners Board of the Public Theater of New… Continue reading Jason Yeung